Type III CRISPR-based RNA editing for programmable control of SARS-CoV-2 and human coronaviruses.

Lin P, Shen G, Guo K, Qin S, Pu Q, Wang Z, Gao P, Xia Z, Khan N, Jiang J, Xia Q, Wu M
Nucleic Acids Res. 2022 May 6;50(8):e47. doi: 10.1093/nar/gkac016. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.